{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:25:21Z","timestamp":1780061121043,"version":"3.54.0"},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Cosmetic Dermatology"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Since there is currently no conclusion on the efficacy and adverse effects of oxymetazoline, this meta\u2010analysis attempts to explore its efficacy and adverse events, so as to provide guidance for clinical medication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched PubMed, Embase, and Cochrane Library from the establishment of the database to May 2021. We included studies that patients were randomly assigned to receive oxymetazoline or vehicle, and we excluded duplicate publications, research without full text, incomplete information or inability to conduct data extraction, animal experiments, reviews, and systematic reviews. STATA 15.1 was used to analyze the data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The pooled results show that the 3 (RR\u2009=\u20091.76, 95% CI: 1.53\u20132.03), 6 (RR\u2009=\u20091.71, 95% CI: 1.47\u20132.00), 9 (RR\u2009=\u20091.63, 95% CI: 1.40\u20131.90), 12 (RR\u2009=\u20091.41, 95% CI: 1.18\u20131.67) \u2010hours CEA success rate and the 3 (RR\u2009=\u20091.65, 95% CI: 1.34\u20132.03), 6 (RR\u2009=\u20091.75, 95% CI: 1.43\u20132.14), 9 (RR\u2009=\u20091.63, 95% CI: 1.33\u20132.00), 12 (RR\u2009=\u20091.78, 95% CI: 1.45\u20132.18) \u2010hours SSA success rate after oxymetazoline treatment for rosacea is significantly higher than that of vehicle. Additionally, the pooled results show that the incidence of TEAEs after treatment with oxymetazoline is significantly higher than that of vehicle (RR\u2009=\u20091.34, 95% CI: 1.10\u20131.2). However, our analysis of specific adverse events found that the oxymetazoline group was only significantly higher than the vehicle group in the incidence of application\u2010site dermatitis (RR\u2009=\u20098.91, 95% CI: 1.76\u201345.23), and there was no statistical significance in the difference in the incidence of other adverse events.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Oxymetazoline is effective and can be selected for the treatment of persistent facial erythema of rosacea. Additionally, application\u2010site dermatitis was the most important one.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jocd.15747","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T07:44:12Z","timestamp":1683013452000},"page":"2408-2419","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of oxymetazoline for the treatment of rosacea: A meta\u2010analysis"],"prefix":"10.1111","volume":"22","author":[{"given":"Fei","family":"Liu","sequence":"first","affiliation":[{"name":"Jinhua People's Hospital  Jinhua China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-3423","authenticated-orcid":false,"given":"Qiujun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of First Clinical Medical College Zhejiang Chinese Medical University  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of First Clinical Medical College Zhejiang Chinese Medical University  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Fu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maocan","family":"Tao","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Luo","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine)  Hangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"e_1_2_11_2_1","first-page":"725","article-title":"Diagnosis and treatment of rosacea: state of the art","volume":"11","author":"Baldwin HE","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120625"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1370370"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2009.09.2066"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2011.09.002"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpp.763"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.05.036"},{"key":"e_1_2_11_9_1","first-page":"435","article-title":"Rosacea: a common, yet commonly overlooked, condition","volume":"66","author":"Blount BW","year":"2002","journal-title":"Am Fam Physician"},{"key":"e_1_2_11_10_1","first-page":"26","article-title":"Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea","volume":"5","author":"Del Rosso JQ","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13557"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-015-0156-2"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.11.1369"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1983.01040020124022"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.19163"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533446"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.06.009"},{"key":"e_1_2_11_19_1","first-page":"16","article-title":"Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema","volume":"5","author":"Del Rosso JQ","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1639606"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1993.tb01955.x"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.093278"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.05.044"},{"key":"e_1_2_11_24_1","first-page":"17","article-title":"The burden of illness of erythematotelangiectatic rosacea and papulopustular rosacea: findings from a web\u2010based survey","volume":"10","author":"Del Rosso JQ","year":"2017","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["Journal of Cosmetic Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocd.15747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T10:29:38Z","timestamp":1691749778000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocd.15747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1111\/jocd.15747"],"URL":"https:\/\/doi.org\/10.1111\/jocd.15747","archive":["Portico"],"relation":{},"ISSN":["1473-2130","1473-2165"],"issn-type":[{"value":"1473-2130","type":"print"},{"value":"1473-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"2022-10-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}